Soleno Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLNO and other ETFs, options, and stocks.About SLNO
Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder.
CEOAnish Bhatnagar
CEOAnish Bhatnagar
Employees42
Employees42
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded1999
Founded1999
Employees42
Employees42
SLNO Key Statistics
Market cap1.61B
Market cap1.61B
Price-Earnings ratio-15.98
Price-Earnings ratio-15.98
Dividend yield—
Dividend yield—
Average volume672.92K
Average volume672.92K
High today$49.19
High today$49.19
Low today$47.10
Low today$47.10
Open price$47.10
Open price$47.10
Volume66.66K
Volume66.66K
52 Week high$53.82
52 Week high$53.82
52 Week low$3.48
52 Week low$3.48
SLNO News
TipRanks 2d
Soleno Therapeutics announces publication of data comparing DCCR treatmentSoleno Therapeutics announced the publication of the comparison of results from the Company’s Phase 3 placebo-controlled study and open-label extension study ev...
TipRanks 3d
Soleno Therapeutics receives BTD from U.S. FDA for diazoxide cholineSoleno Therapeutics announced that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, to diazoxide choline for the t...
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%